Overview

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Status:
RECRUITING
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
To learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy on depression and/or anxiety in participants who are being treated for advanced cancer.
Phase:
PHASE2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Gateway for Cancer Research
Treatments:
Niacin
Psilocybin